|
Feb 24
|
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
|
|
Feb 23
|
Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts
|
|
Feb 13
|
Is Stevanato Group S.p.A. (STVN) the Best Italian Stock to Buy in 2025?
|
|
Oct 4
|
CPRX or STVN: Which Is the Better Value Stock Right Now?
|
|
Oct 1
|
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
|
|
Sep 30
|
Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors?
|
|
Sep 12
|
Here’s What Weighed on Stevanato Group S.p.A.’s (STVN) Results
|
|
Sep 11
|
Should You Hold Stevanato Group S.p.A. (STVN)?
|
|
Aug 29
|
Stevanato Group to Present at Upcoming Investor Conferences
|
|
Jul 25
|
Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024
|
|
Jul 24
|
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
|
|
May 12
|
Stevanato Group S.p.A. (NYSE:STVN) Q1 2024 Earnings Call Transcript
|
|
May 12
|
Stevanato Group S.p.A. Just Missed EPS By 34%: Here's What Analysts Think Will Happen Next
|
|
May 10
|
Stevanato Group First Quarter 2024 Earnings: EPS: €0.071 (vs €0.11 in 1Q 2023)
|
|
May 10
|
Q1 2024 Stevanato Group SpA Earnings Call
|
|
May 9
|
Italy Based Stevanato Reports Mixed Q1 Earnings, Revises Annual Guidance On Temporary Destocking
|
|
May 9
|
Stevanato Group Reports Financial Results for the First Quarter of 2024
|
|
May 2
|
Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
May 1
|
Stevanato Group to Present at the Bank of America Securities Healthcare Conference
|
|
Apr 25
|
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
|